CDT Equity Inc.

US$1.31As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CDTHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (99.34%)
Div yield —
ROE (69.68%)
Biotechnology
Beta (5Y) 1.69
PE TTM —
TSR TTM (100.00%)
Mkt cap US$0.074M
ROIC (28.73%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.42
8.57%
134.69%
Hold 6|3|1|12|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.02
0.03
0.03
21.12%
7.52%
14.51%
6.27%
Revenue$M
—
—
—
—
6.56%
3.74%
(2.71%)
(6.77%)
Peers (US$0.074M)
Cap (US$)
PE
0.453M
—
0.126M
—
Capital
TTM
5Y
10Y
Leveragex
2.053
2.388
2.061
EBIT/Intx
1.561
0.318
0.294
Own earn%
108.02
(27.30)
(28.44)
Sh yield%
36.48
20.98
21.70
Owners
Insiders/Inst%
4.70
47.84
Short interest%
0.89
SBC / revenue%
0.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
2–9
$1 testx
−0.1
Incr. ROIC%
7